Forget SCHD: 4 Dividend Stocks Retirees Should Own Instead
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
The Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) grounds countless retirement portfolios. SCHD screens for durable dividend payers, holds $112.3 billion[1] in net assets and pays a trailing yield near 2.94%. Retirees hold SCHD because it delivers quality income without forcing them to pick stocks. That income, however, has barely grown. Four blue-chip dividend payers, led by AbbVie (NYSE:ABBV | ABBV Price Prediction) and Johnson & Johnson (NYSE:JNJ), are raising their payouts faster, cover them well, and charge no fund fee.
Why SCHD Earns Its Place in Retirement Accounts
SCHD’s price rose 36.24% over the past year, and its largest holding made up only 4.76%[1] of assets as of August 31. A dividend cut at any one company barely registers. That protection is real, and four individual stocks can’t fully copy it.
Where SCHD’s Income Falls Short
SCHD paid $1.0541 per share over the trailing 12 months, only 1.95% more than in the prior 12 months. The quarterly checks also bounce around: $0.2782 in December 2025, then $0.2525 in June 2026. If you live on that income, raises under 2% a year lose ground to rising costs.
Four Stocks That Raise Their Payouts Faster
AbbVie: Fastest Dividend Growth
AbbVie yields 2.24% and just raised its quarterly dividend 5.2% to $1.82. That payout was $1.30 in 2021, which works out to about 7% annual growth. The $7.28 forward dividend uses roughly 52% of the center of 2026 adjusted EPS guidance ($13.95 to $13.99), and its free cash flow yield covers the dividend about 1.5 times. SCHD’s August 31 holdings list does not include AbbVie. The risk: Humira sales fell 31.2% last quarter as biosimilars take share.
Johnson & Johnson: Lowest Payout Ratio
Johnson & Johnson yields about 1.90% and has raised its dividend for 64 consecutive years. Its $5.36 annualized dividend uses only about 46% of guided 2026 adjusted EPS, which leaves ample room for future raises. SCHD doesn’t hold it either. The risk: Stelara revenue fell 55.2% in the second quarter, and litigation charges of $267M continue to repeat.
Procter & Gamble: 70 Years of Raises
Procter & Gamble (NYSE:PG) yields about 2.52%, the highest of the four, and has raised its dividend for 70 consecutive years. Fiscal 2026 free cash flow of $15.835 billion well funds the over $10 billion in dividends P&G plans for fiscal 2027. The risk: management expects a commodity-cost pressure of about $1.4 billion after tax.
Coca-Cola: Steady but Expensive
Coca-Cola (NYSE:KO) yields 2.05% after a 3.9% raise to $0.53 a quarter. Management’s 2026 free cash flow target of at least $13.0 billion covers a dividend bill of roughly $9.1 billion. The risk: at 33 times earnings, the stock leaves little buffer if growth slows.
What You Give Up by Leaving SCHD
An equal-weight mix of the four yields about 2.18%, so a $100,000 position pays roughly $764 less income in year one than SCHD. You accept less income today in exchange for faster raises later. Concentration risk also jumps: half the basket sits in pharma, where a single patent expiration can hit a quarter of your income. Coca-Cola and P&G already make up 4.16%[1] and 3.82% of SCHD, so those two add little new exposure.
How to Switch Without a Big Tax Bill
Selling inside an IRA creates no tax liability. Long-time holders in taxable accounts likely have large gains, since SCHD rose 254.45% over ten years. Selling highest-cost lots first, or steering fresh savings and SCHD distributions toward the four stocks, are approaches some investors use. Both approaches shift your mix over time without forcing you to realize gains.
Which Investors Gain Most From Faster Dividend Growth
Investors who need maximum current income get the larger payout today from SCHD’s higher yield. For retirees with a decade or more ahead, the faster dividend growth at AbbVie, Johnson & Johnson, P&G and Coca-Cola has more time to compound. The comparison would shift if SCHD’s payout growth speeds up after its next reconstitution, or if any of the four companies slows its raises or lets its payout ratio climb.
Contact [email protected] for any questions or corrections.








